Updated on 9 September 2026
In vitro safety and efficacy testing for finished cosmetics and substance-based medical devices
General Manager at BiCT srl
Lodi, Italy
About
We test finished cosmetics and substance-based medical devices for the companies that develop them. On the safety side: in vitro skin irritation according to OECD TG 439 on reconstructed human epidermis, cytotoxicity and sensitisation, skin absorption, in vivo patch test, microbiological challenge and stability, delivered in the form the safety assessor expects in the dossier. On the efficacy side we measure the effect being claimed, from anti-age and soothing to hydration and barrier, brightening, anti-acne, antioxidant, microbiome and photoprotection. For substance-based medical devices we work on 3D mucosal models with their own vocabulary: barrier effect, mucoadhesion and retention measured as adhesion force, mucolytic action, cytoprotection, hydration and lubrication with friction measurement, plus biocompatibility along the full ISO 10993 series. Skin, mucosal and ingested devices are all covered.
Similar opportunities
Partnership
Three proprietary actives from fermentation, looking for formulators and distributors
Silvia Rapacioli
General Manager at BiCT srl
Lodi, Italy
Partnership
Evaluate our extract for develop final products
Alessio Gaggiotti
Founder at Farmech Società agricola SRL
Perugia, Italy
Partnership
Innovation in fermented foods, feeds and supplements
Antonio Del Casale
CEO & Business Development at Microbion - Microbiology Open Innvoation
Verona, Italy